Insider Shareholders with Direct Ownership of Candel Therapeutics, Inc. (CADL)
This section provides a comprehensive overview of the insiders with direct ownership of Candel Therapeutics, Inc. (CADL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Candel Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Laura K. Aguilar
> 10% Shareholder |
227,431 | 68,534 | 1,033,840 $6.95 Million | 3 |
May 06, 2022
Reduced 6.22%
|
|
Paul Peter Tak
Chief Executive Officer |
429,899 | 177,987 | 251,912 $1.69 Million | 12 |
Jan 15, 2025
Reduced 7.93%
|
|
Jason Amello
Chief Financial Officer |
222,162 | 20,153 | 202,009 $1.36 Million | 5 |
Nov 28, 2023
Reduced 9.07%
|
| 27,000 | 0 | 152,000 $1.02 Million | 2 |
Dec 09, 2022
Added 13.61%
|
|
|
Francesca Barone
Chief Scientific Officer |
204,905 | 95,732 | 110,673 $743,722 | 9 |
Jan 15, 2025
Reduced 10.9%
|
|
Seshu Tyagarajan
Chief Technology Officer |
191,558 | 94,768 | 96,790 $650,428 | 10 |
Jan 15, 2025
Reduced 12.89%
|
|
Estuardo Aguilar Cordova
> 10% Shareholder |
353,534 | 927,703 | 91,335 $613,771 | 29 |
Dec 06, 2024
Reduced 17.96%
|
|
William Garrett Nichols
Chief Medical Officer |
147,301 | 67,981 | 79,320 $533,030 | 8 |
Jan 15, 2025
Reduced 11.62%
|
| 56,000 | 0 | 56,000 $376,320 | 2 |
Jul 29, 2021
Added 26.32%
|
|
| 0 | 38,263 | 43,038 $289,215 | 4 |
Jan 15, 2025
Reduced 18.1%
|
|
| 38,032 | 0 | 38,032 $255,575 | 2 |
Dec 09, 2022
Added 47.94%
|
|
|
John J Canepa
Chief Financial Officer |
10,125 | 0 | 10,125 $68,040 | 1 |
Jul 29, 2021
Added 50.0%
|
| 10,000 | 0 | 10,000 $67,200 | 1 |
Jul 29, 2021
Added 50.0%
|
|
|
Nathan Caffo
Chief Business Officer |
6,000 | 0 | 6,000 $40,320 | 1 |
Jul 29, 2021
Added 50.0%
|